Blood clearance of the prion protein introduced by intravenous route in sheep is influenced by host genetic and physiopathologic factors

Transfusion

Volumn 48, Issue 4, 2008, Pages 609-619

  Gayrard, Véronique ^b   Picard Hagen, Nicole ^b   Viguié, Catherine ^b   Jeunesse, Elisabeth ^b   Tabouret, Guillaume ^b   Rezaei, Human ^b   Toutain, Pierre Louis ^a  

^a UNIVERSITÉ DE TOULOUSE   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PRION PROTEIN; PROTEINASE K;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; GENOTYPE; HEREDITY; NEPHRECTOMY; NONHUMAN; PATHOPHYSIOLOGY; PLASMA CLEARANCE; PROKARYOTE; SCRAPIE; SHEEP;

ANIMALS; GENOTYPE; IMMUNOASSAY; INJECTIONS, INTRAVENOUS; KINETICS; NEPHRECTOMY; PRIONS; RECOMBINANT PROTEINS; SCRAPIE; SHEEP;

EID: 41149098713     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2007.01628.x     Document Type: Article

References (45)

1. Schmerr MJ, Jenny AL, Bulgin MS, Miller JM, Hamir AN, Cutlip RC, Goodwin KR. Use of capillary electrophoresis and fluorescent labeled peptides to detect the abnormal prion protein in the blood of animals that are infected with a transmissible spongiform encephalopathy. J Chromatogr A 1999 853 : 207 14.
2. Herrmann LM, Baszler TV, Knowles DP, Cheevers WP. PrP(Sc) is not detected in peripheral blood leukocytes of scrapie-infected sheep: determining the limit of sensitivity by immunohistochemistry. Clin Diagn Lab Immunol 2002 9 : 499 502.
3. Brown P, Cervenakova L, McShane LM, Barber P, Rubenstein R, Drohan WN. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999 39 : 1169 78.
4. Hunter N, Foster J, Chong A, McCutcheon S, Parnham D, Eaton S, MacKenzie C, Houston F. Transmission of prion diseases by blood transfusion. J Gen Virol 2002 83 : 2897 905.
5. Houston EF, Halliday SI, Jeffrey M, Goldmann W, Hunter N. New Zealand sheep with scrapie-susceptible PrP genotypes succumb to experimental challenge with a sheep-passaged scrapie isolate (SSBP/1). J Gen Virol 2002 83 : 1247 50.
6. Houston F, Foster JD, Chong A, Hunter N, Bostock CJ. Transmission of BSE by blood transfusion in sheep. Lancet 2000 356 : 999 1000.
7. Herzog C, Sales N, Etchegaray N, Charbonnier A, Freire S, Dormont D, Deslys JP, Lasmezas I. Tissue distribution of bovine spongiform encephalopathy agent in primates after intravenous or oral infection. Lancet 2004 363 : 422 8.
8. Wroe SJ, Pal S, Siddique D, Hyare H, MacFarlane R, Joiner S, Linehan JM, Brandner S, Wadsworth JD, Hewitt P, Collinge J. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 2006 368 : 2061 7.
9. Editorial team. Fourth case of transfusion-associated vCJD infection in the United Kingdom. Euro Surveill 2007 12 : E070118.4.
10. Wilson K, Ricketts MN. A third episode of transfusion-derived vCJD. Lancet 2006 368 : 2037 9.
11. Hunter N, Goldmann W, Foster JD, Cairns D, Smith G. Natural scrapie and PrP genotype: case-control studies in British sheep. Vet Rec 1997 141 : 137 40.
12. Elsen JM, Amigues Y, Schelcher F, Ducrocq V, Andreoletti O, Eychenne F, Khang JV, Poivey JP, Lantier F, Laplanche JL. Genetic susceptibility and transmission factors in scrapie: detailed analysis of an epidemic in a closed flock of Romanov. Arch Virol 1999 144 : 431 45.
13. Baylis M, Chihota C, Stevenson E, Goldmann W, Smith A, Sivam K, Tongue S, Gravenor MB. Risk of scrapie in British sheep of different prion protein genotype. J Gen Virol 2004 85 : 2735 40.
14. Le Dur A, Beringue V, Andreoletti O, Reine F, Lai TL, Baron T, Bratberg B, Vilotte JL, Sarradin P, Benestad SL, Laude H. A newly identified type of scrapie agent can naturally infect sheep with resistant PrP genotypes. Proc Natl Acad Sci U S A 2005 102 : 16031 6.
15. Rezaei H, Marc D, Choiset Y., Takahashi M, Hui Bon Hoa G, Haertlé T, Grosclaude J, Debey P. High yield purification and physico-chemical properties of full-length recombinant allelic variants of sheep prion protein linked to scrapie susceptibility. Eur J Biochem 2000 267 : 2833 9.
16. Rezaei H, Choiset Y, Eghiaian F, Treguer E, Mentre P, Debey P, Haertle T, Grosclaude J. Amyloidogenic unfolding intermediates differentiate sheep prion protein variants. J Mol Biol 2002 322 : 799 814.
17. Maack T, Johnson V, Kau ST, Figueiredo J, Sigulem D. Renal filtration, transport, and metabolism of low-molecular weight proteins. A review. Kidney Int 1979 16 : 251 70.
18. Horney D, Archibald J. Nephrectomy in cattle and sheep. J Am Vet Med Assoc 1961 138 : 551 2.
19. Grassi J, Creminon C, Frobert Y, Fretier P, Turbica I, Rezaei H, Hunsmann G, Comoy E, Deslys JP. Specific determination of the proteinase K-resistant form of the prion protein using two-site immunometric assays. Application to the post-mortem diagnosis of BSE. Arch Virol Suppl 2000 16 : 197 205.
20. Feraudet C, Morel N, Simon S, Volland H, Frobert YF, Creminon C, Vilette D, Lehmann S, Grassi J. Screening of 145 anti-PrP monoclonal antibodies for their capacity to inhibit PrPSc replication in infected cells. J Biol Chem 2005 280 : 11247 58.
21. Fischer MB, Roeckl C, Parizek P, Schwarz HP, Aguzzi A. Binding of disease-associated prion protein to plasminogen. Nature 2000 408 : 479 83.
22. Maissen M, Roeckl C, Glatzel M, Goldmann W, Aguzzi A. Plasminogen binds to disease-associated prion protein of multiple species. Lancet 2001 357 : 2026 8.
23. Gibaldi M, Perrier D. Pharmacokinetics. 2nd ed. New York : Marcel Dekker 1982.
24. Kong AN, Jusko WJ. Definitions and application of mean residence times in reference to the two-compartment mammillary plasma clearance model. J Pharm Sci 1988 77 : 157 65.
25. Nesje M, Flaoyen A, Moe L. Estimation of glomerular filtration rate in normal sheep by the disappearance of iohexol from serum. Vet Res Commun 1997 21 : 29 35.
26. Rowland M, Tozer TN. Clinical pharmacokinetics. Concepts and applications. 3rd ed. New York : Lea & Febiger 1995.
27. Maack T, Park CH, Camargo MJ. Renal filtration, transport and metabolism of proteins. In : Seldin DW, Giebish G, editors. The kidney physiology and pathophysiology. New York : Raven Press 1992. p. 3 005 38.
28. Calzolai L, Zahn R. Influence of pH on NMR structure and stability of the human prion protein globular domain. J Biol Chem 2003 278 : 35592 6.
29. De Simone A, Dodson GG, Verma CS, Zagari A, Fraternali F. Prion and water: tight and dynamical hydratation sites have a key role in structural stability. Proc Natl Acad Sci U S A 2005 102 : 7535 40.
30. Sc conversion from the structures of antibody-bound ovine prion scrapie-susceptibility variants. Proc Natl Acad Sci U S A 2004 101 : 10254 9.
31. Haire LF, Whyte SM, Vasisht N, Gill AC, Verma C, Dodson EJ, Dodson GG, Bayley PM. The crystal structure of the globular domain of sheep prion protein. J Mol Biol 2004 336 : 1175 83.
32. Hornemann S, Schorn C, Wüthrich K. NMR structure of the bovine prion protein isolated from healthy calf brains. EMBO Rep 2004 5 : 1159 64.
33. Zahn R, Güntert P, Von Schroetter C, Wüthrich K. NMR structure of a variant human prion protein with two sulfide bridges. J Mol Biol 2003 326 : 225 34.
34. Chesebro B, Trifilo M, Race R, Meade-White K, Teng C, LaCasse R, Raymond L, Favara C, Baron G, Priola S, Caughey B, Masliah E, Oldstone M. Anchorless prion protein results in infectious amyloid disease without clinical scrapie. Science 2005 308 : 1435 9.
35. Legname G, Baskakov IV, Nguyen HO, Riesner D, Cohen FE, De Armond SJ, Prusiner SB. Synthetic mammalian prions. Science 2004 305 : 673 6.
36. Halliday S, Houston F, Hunter N. Expression of PrPC on cellular components of sheep blood. J Gen Virol 2005 86 : 1571 9.
37. Thackray AM, Fitzmaurice TJ, Hopkins L, Bujdoso R. Ovine plasma prion protein levels show genotypic variation detected by C-terminal epitopes not exposed in cell-surface PrPc. Biochem J 2006 400 : 349 58.
38. Starke R, Drummond O, MacGregor I, Biggerstaff J, Camilleri R, Gale R, Lee CA, Nitu-Whalley S, Machin SJ, Harrison P. The expression of prion protein by endothelial cells: a source of the plasma form of prion protein? Br J Haematol 2002 119 : 863 73.
39. Starke R, Mackie I, Drummond O, MacGregor I, Harrison P, Machin S. Prion protein in patients with renal failure. Transfus Med 2006 16 : 165 8.
40. Foster PR. Selection of spiking materials for studies on the clearance of agents of transmissible spongiform encephalopathy during plasma fractionation. Biologicals 2007 Mar 30 : 1 2.
41. Brown P, Cervenakova L, McShane LM, Barber P, Rubenstein R, Drohan WN. Further studies of blood infectivity in an experimental model of transmissible spongiform encephalopathy, with an explanation of why blood components do not transmit Creutzfeldt-Jakob disease in humans. Transfusion 1999 39 : 1169 78.
42. Yakovleva O, Janiak A, McKenzie C, McShane L, Brown P, Cervenakova L. Effect of protease treatment on plasma infectivity in variant Creutzfeldt-Jakob disease mice. Transfusion 2004 44 : 1700 5.
43. Post K, Brown DR, Groschup M, Kretzschmar HA, Riesner D. Neurotoxicity but not infectivity of prion proteins can be induced reversibly in vitro. Arch Virol Suppl 2000 16 : 265 73.
44. Wille H, Prusiner SB. Ultrastructural studies on scrapie prion protein crystals obtained from reversed micellar solutions. Biophys J 1999 76 : 1048 62.
45. Berardi VA, Cardone F, Valanzano A, Lu M, Pocchiari M. Preparation of soluble infectious samples from scrapie-infected brain: a new tool to study the clearance of transmissible spongiform encephalopathy agents during plasma fractionation. Transfusion 2006 46 : 652 8.